相似文献
1
The Search for an HIV Cure: Where Do We Go From Here?
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):1-3. doi: 10.1093/infdis/jiaa738.
2
Challenges and Promise of Human Immunodeficiency Virus Remission.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):4-12. doi: 10.1093/infdis/jiaa568.
3
Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy.
Viruses. 2020 Feb 8;12(2):188. doi: 10.3390/v12020188.
4
Progress in achieving long-term HIV remission.
Curr Opin HIV AIDS. 2018 Sep;13(5):435-445. doi: 10.1097/COH.0000000000000487.
5
Fight fire with fire: Gene therapy strategies to cure HIV.
Expert Rev Anti Infect Ther. 2017 Aug;15(8):747-758. doi: 10.1080/14787210.2017.1353911. Epub 2017 Jul 14.
6
Controversies in HIV cure research.
J Int AIDS Soc. 2012 Mar 16;15(1):16. doi: 10.1186/1758-2652-15-16.
7
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
Ann Intern Med. 2014 Sep 2;161(5):319-27. doi: 10.7326/M14-1027.
8
Which therapeutic strategy will achieve a cure for HIV-1?
Curr Opin Virol. 2016 Jun;18:14-9. doi: 10.1016/j.coviro.2016.02.001. Epub 2016 Mar 15.
9
Advances toward Curing HIV-1 Infection in Tissue Reservoirs.
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.00375-19.
10
Toward HIV eradication or remission: the tasks ahead.
Science. 1998 Jun 19;280(5371):1866-7. doi: 10.1126/science.280.5371.1866.
引用本文的文献
1
Methamphetamine Enhancement of HIV-1 gp120-Mediated NLRP3 Inflammasome Activation and Resultant Proinflammatory Responses in Rat Microglial Cultures.
Int J Mol Sci. 2024 Mar 22;25(7):3588. doi: 10.3390/ijms25073588.
2
Methamphetamine enhancement of HIV-1 gp120-mediated NLRP3 inflammasome activation and resultant proinflammatory responses in rat microglial cultures.
Res Sq. 2023 Dec 16:rs.3.rs-3707515. doi: 10.21203/rs.3.rs-3707515/v1.
3
Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
PLoS Pathog. 2021 Oct 21;17(10):e1010014. doi: 10.1371/journal.ppat.1010014. eCollection 2021 Oct.
本文引用的文献
1
The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):46-53. doi: 10.1093/infdis/jiaa681.
2
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):13-21. doi: 10.1093/infdis/jiaa649.
3
Challenges and Promise of Human Immunodeficiency Virus Remission.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):4-12. doi: 10.1093/infdis/jiaa568.
4
Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):22-31. doi: 10.1093/infdis/jiaa165.
5
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):32-37. doi: 10.1093/infdis/jiaa333.
6
Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy.
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):38-45. doi: 10.1093/infdis/jiaa223.
7
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.
Lancet HIV. 2020 May;7(5):e340-e347. doi: 10.1016/S2352-3018(20)30069-2. Epub 2020 Mar 10.
8
Structural topology defines protective CD8 T cell epitopes in the HIV proteome.
Science. 2019 May 3;364(6439):480-484. doi: 10.1126/science.aav5095.
9
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Nature. 2019 Apr;568(7751):244-248. doi: 10.1038/s41586-019-1027-4. Epub 2019 Mar 5.
10
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.
Nature. 2019 Feb;566(7742):120-125. doi: 10.1038/s41586-019-0898-8. Epub 2019 Jan 30.
Zotero 插件